Arcus Biosciences (RCUS) FCF Margin Growth (1y) (2018 - 2026)
Arcus Biosciences (RCUS) FCF Margin Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
FCF Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
5,389.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,525.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Arcus Biosciences |
3.05 Bn |
2.23 Bn |
- |
-33,676.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-33,676.00 |
| Dec 31, 2025 |
2,786.00 |
| Sep 30, 2025 |
-42,516.00 |
| Jun 30, 2025 |
16,559.00 |
| Mar 31, 2025 |
-47,293.00 |
| Dec 31, 2024 |
12,582.00 |
| Sep 30, 2024 |
28,021.00 |
| Jun 30, 2024 |
-3,492.00 |
| Mar 31, 2024 |
40,193.00 |
| Dec 31, 2023 |
-30,840.00 |
| Sep 30, 2023 |
2,339.00 |
| Jun 30, 2023 |
3,806.00 |
| Mar 31, 2023 |
-403,178.00 |
| Dec 31, 2022 |
-19,309.00 |
| Sep 30, 2022 |
43,384.00 |
| Jun 30, 2022 |
56,940.00 |
| Mar 31, 2022 |
435,814.00 |
| Dec 31, 2021 |
54,381.00 |
| Sep 30, 2021 |
-102,028.00 |
| Jun 30, 2021 |
54,097.00 |
